Source: Annual Congress 2011 - Rare diffuse lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Ilkovich, L. Novikova, O. Baranova, I. Dvorakovskaya, A. Bazhanov (St. Petersburg, Russian Federation). Long term follow-up in patients with pulmonary alveolar proteinosis. Eur Respir J 2011; 38: Suppl. 55, 638

Member's Comments

No comment yet.

Related content which might interest you: Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Pulmonary alveolar proteinosis, study of 29 cases Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Long clinical course of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 PAS-negative pulmonary alveolar proteinosis Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Pulmonary alveolar proteinosis Source: Eur Respir Mon; 2009: 46: 208–224 Year: 2009 Pulmonary alveolar proteinosis Source: Eur Respir Rev 2011; 20: 98-107 Year: 2011 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Baseline characteristics of an Italian cohort of pulmonary alveolar proteinosis (PAP) patients Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004